Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111095116 | 11109511 | 6 | F | 20160811 | 20150513 | 20160818 | EXP | US-PFIZER INC-2015156767 | PFIZER | 50.00 | YR | F | Y | 57.00000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111095116 | 11109511 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 250 MG, DAILY (200 MG AT NIGHT 50 MG IN MORNING) | 21446 | CAPSULE, HARD | BID | ||||||||
| 111095116 | 11109511 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, DAILY [QD] | 21446 | 200 | MG | CAPSULE, HARD | |||||||
| 111095116 | 11109511 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 1X/DAY (1 CAPSULE IN MORNING) | 21446 | 50 | MG | CAPSULE, HARD | QD | ||||||
| 111095116 | 11109511 | 4 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 111095116 | 11109511 | 5 | C | FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 40 MG, DAILY | 0 | 40 | MG | |||||||||
| 111095116 | 11109511 | 6 | C | TIZANIDINE. | TIZANIDINE | 1 | 4 MG, DAILY | 0 | 4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111095116 | 11109511 | 1 | Fibromyalgia |
| 111095116 | 11109511 | 4 | Cognitive disorder |
| 111095116 | 11109511 | 5 | Depression |
| 111095116 | 11109511 | 6 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111095116 | 11109511 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111095116 | 11109511 | Depression | |
| 111095116 | 11109511 | Gastrointestinal disorder | |
| 111095116 | 11109511 | Memory impairment | |
| 111095116 | 11109511 | Mental impairment | |
| 111095116 | 11109511 | Suicidal ideation | |
| 111095116 | 11109511 | Weight increased | |
| 111095116 | 11109511 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111095116 | 11109511 | 5 | 20141031 | 0 |